Author

Olha Lapshyna

University of Lübeck

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Anna Maxi WandmacheriD· 1 shared Anne Schmidt· 1 shared Anne‐Sophie MehdorniD· 1 shared Annika BräueriD· 1 shared Ashini Kumar HidamiD· 1 shared Benjamin Heckelmann· 1 shared Caj Stach· 1 shared Charlotte KayseriD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Anna Maxi WandmacherORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

L1CAMxCD3 bispecific antibodies exert potent anti-tumor effects in preclinical pancreatic cancer models considering the complex tumor stroma

Anna Maxi Wandmacher, Annika Bräuer, Charlotte Kayser, Caj Stach, Jakob Werner, Silje Beckinger, Tina Daunke, Leon Baumann, Benjamin Heckelmann, Ashini Kumar Hidam, Olha Lapshyna, Daniela Wesch, Anne‐Sophie Mehdorn, Christoph Röcken, Ruediger Braun, , Susanne Sebens

This study shows L1CAMxCD3 bispecific antibodies effectively target PDAC cells in immunosuppressive models, inducing apoptosis and T cell effector molecule release.

bioRxiv · Aug 19, 2026 · PreprintCancer Biology